Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 51655-933

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 51655-933). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-933-04 (51655 933 04 Rev A 10 22)

This is a description of Ondansetron Tablets, USP (4mg). Each tablet contains Ondansetron hydrochloride USP (dihydrate) equivalent to 4mg of ondansetron. The tablets are intended to be taken as directed by a physician, and it is recommended that patients read the package insert for more information on proper dosage. The tablets should be stored in their original container at 20°-25°C, with excursions permitted to 15°-30°C. Patients should keep the tablets out of reach of children and protect from light. GTIN is 00351655933046 and LOT is 0000000000. This medication has been repackaged by Northwind Pharmaceuticals, at Indianapolis, IN 46203.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.